Philippe Lesaulnier
Business Development Manager

About

Philippe Lesaulnier was Business Development Manager at Biocorp, in charge of finding opportunities for non-connected devices from Biocorp’s range and customised solutions for pharmaceutical companies. Operating in the pharmaceutical packaging sector for 25 years, Philippe has worked for companies like West, Rexam and Gerresheimer, in charge of major pharmaceutical accounts on a worldwide basis. Specialised in primary packaging for parenteral products, he has a combined technical background (electronics and mechanics) and numerous business experiences.

Contributions

PREFILLED SYRINGES

A MODEL FOR TRANSFORMING BREAKTHROUGH INNOVATIONS IN SUCCESSFUL PRODUCTS

Eric Dessertenne, Philippe Lesaulnier and Arnaud Guillet outline Biocorp’s approach to device design and detail two products in the company’s portfolio, Newguard and Easylog, which are anticipated for market launch next year.

More contributions

PREFILLED SYRINGES

NEWGUARD – PAVING THE WAY FOR A NEW SAFETY STANDARD

Needlestick injuries remain a serious concern for pharmaceutical companies involved in injectable drugs. Biocorp has been developing NewGuard™, an integrated passive safety device to tackle this problem. Throughout the development phase, Biocorp defined key elements to ensure NewGuard™ will not require unnecessary changes to be made to the PFS manufacturing process. Philippe Lesaulnier and Eric Dessertenne explain more.

PREFILLED SYRINGES

SAFER PREFILLED SYRINGES & FEWER PROCESS CHANGES

Jean Vuillecard, Philippe Lesaulnier and Eric Dessertenne explain how, despite great innovations, adopting new syringe safety systems has always been a trade-off between safety and the cost of implementing new processes and introduce Biocorp's Newguard™, a new passive safety system integrated on prefilled syringes without such compromises being required.